The medical device industry is entering a new regulatory era. The U.S. Food and Drug Administration (FDA) has introduced the Quality Management System Regulation (QMSR), a major update that changes how manufacturers maintain and demonstrate compliance. As the FDA QMSR deadline approaches, companies must understand what the new requirements mean and how they affect existing quality management systems.
Organizations that manufacture, distribute, or supply medical devices must review their current processes and prepare for regulatory expectations. A strong focus on documentation, supplier oversight, risk management, and quality controls will play an important role in meeting FDA requirements. Understanding the transition early can help organizations move toward compliance with confidence.
The discussion around QMSR vs. 21 CFR 820 often centers on harmonization. Manufacturers that already follow ISO 13485 may find the transition more manageable, although FDA-specific obligations still apply.
What is the QMSR?
Many industry professionals ask, “What is FDA QMSR regulation?” In simple terms, QMSR is the FDA’s updated quality management framework for medical device manufacturers. The regulation incorporates key elements of ISO 13485:2016 into FDA requirements to create a more globally aligned quality system approach. The FDA introduced QMSR to modernize quality management expectations and reduce differences between U.S. and international regulations. Rather than maintaining separate systems for different markets, manufacturers can work toward a more harmonized quality management framework. Organizations involved in medical device manufacturer compliance should understand that QMSR does not eliminate FDA oversight. Instead, it updates quality system expectations while maintaining FDA authority and enforcement capabilities.QMSR vs 21 CFR 820: Key Changes
Many manufacturers want to know, “How does QMSR replace 21 CFR 820?” The FDA has revised its quality system framework by incorporating ISO 13485 concepts while preserving certain FDA-specific requirements.| Quality Area | 21 CFR 820 | QMSR Approach |
| Design Controls | Detailed FDA-specific requirements | Integrated with ISO 13485 processes |
| Risk Management | Limited references | Greater emphasis throughout the quality system |
| Process Validation | Separate validation requirements | Closer alignment with international standards |
| Complaint Handling | FDA-focused procedures | Harmonized approach with continued FDA reporting obligations |
Medical Device Supplier Audit Requirements Under QMSR
A medical device supplier audit remains an essential component of quality system compliance. Suppliers contribute directly to product quality, safety, and regulatory performance. Under QMSR, organizations must demonstrate that suppliers meet established quality requirements and consistently provide compliant products and services. Companies should establish documented supplier qualification procedures, monitor supplier performance, and maintain records that support regulatory expectations. Internal teams often use a medical device supplier audit to identify risks before they affect manufacturing operations or product quality. As regulatory scrutiny increases, supplier management programs must become more structured and evidence-based. Organizations should review supplier controls well before FDA inspections occur.How QMSR aligns with ISO 13485:2016 (and why that matters)
One of the most significant aspects of the regulation is ISO 13485 QMSR alignment. The FDA recognized that many medical device companies already operate within ISO-certified environments. By aligning regulatory expectations with ISO 13485:2016, the agency aims to create consistency across global markets. This alignment encourages organizations to maintain quality management systems that satisfy both international and U.S. regulatory expectations. However, alignment does not mean automatic compliance. Companies must verify that all FDA-specific requirements remain properly addressed. Organizations should conduct a medical device quality system audit to identify gaps between current practices and new QMSR expectations. Gap assessments provide valuable insight into areas that may require updates before enforcement activities increase.Compliance Readiness Checklist
Organizations preparing for FDAQMSR compliance in 2024–2025 should complete several important readiness activities.- Review current quality management procedures against QMSR requirements.
- Assess supplier qualification and monitoring processes.
- Evaluate risk management documentation and controls.
- Verify complaint handling procedures and reporting practices.
- Review design control documentation and product lifecycle records.
- Confirm process validation activities remain current and documented.
- Conduct internal audits to identify compliance gaps.
- Prepare management review records and quality metrics.
- Train employees on updated regulatory expectations.
- Schedule independent assessments before regulatory inspections.